Intravitreal anti-VEGF treatment for subretinal neovascularisation secondary to type 2 idiopathic juxtafoveolar telangiectasia
Article
Barth, Teresa, Zeman, Florian, Helbig, Horst and Gamulescu, Maria-Andreea (2017) Intravitreal anti-VEGF treatment for subretinal neovascularisation secondary to type 2 idiopathic juxtafoveolar telangiectasia. International Ophthalmology.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | International Ophthalmology | ||||
| Publisher | Springer | ||||
| Place of Publication | DORDRECHT | ||||
| Date | 2017 | ||||
| Date of publication | 28 Jul 2021 17:23 | ||||
| Institutions | Medicine > Lehrstuhl für Augenheilkunde | ||||
| Identification Number |
| ||||
| Keywords | GROWTH-FACTOR THERAPY; MACULAR TELANGIECTASIA; PHOTODYNAMIC THERAPY; BEVACIZUMAB AVASTIN; RETINAL TELANGIECTASIS; RANIBIZUMAB; 2A; MEMBRANE; Subretinal neovascular membrane; Idiopathic juxtafoveolar telangiectasia; Intravitreal antiangiogenic therapy; Anti-VEGF (vascular endothelial growth factor) | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 47486 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric